Pomalidomide-C2-acid
CAS No. 2225940-46-3
Pomalidomide-C2-acid( —— )
Catalog No. M28264 CAS No. 2225940-46-3
Pomalidomide-C2-acid is a PROTAC building block.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 49 | In Stock |
|
| 100MG | 90 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePomalidomide-C2-acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-C2-acid is a PROTAC building block.
-
DescriptionPomalidomide-C2-acid is a PROTAC building block.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorRac1|Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225940-46-3
-
Formula Weight345.31
-
Molecular FormulaC16H15N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(CCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cardama GA, et al. Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells. Onco Targets Ther. 2014;7:2021‐2033. Published 2014 Oct 30.
molnova catalog
related products
-
Swertiachoside B
Swertiachoside B
-
Vicine
Vicine an alkaloid found in fava beans is toxic in individuals and may cause haemolytic anaemia.
-
Eldacimibe
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
Cart
sales@molnova.com